Pointe Capital Management LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1640335
GROSSE POINTE FARMS, MI
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$472,019
-$159,227 QoQ
Shares Held
757
-7.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#821
of 1,322 holders
Holding Since
Dec 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pointe Capital Management LLC holds $472,019 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
757 | $472,019 |
All Filings in REGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $472,019 | 757 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $631,246 | 817 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $653,002 | 846 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $404,272 | 719 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $275,625 | 525 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $329,165 | 519 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $376,110 | 528 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $358,472 | 341 | Shares | Sole | 2024-10-24 | |
| 2023-03-31 | $108,460 | 132 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $398,797 | 571 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $351,756 | 557 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||